Skip to main content
Erschienen in: Journal of Neuro-Oncology 2/2016

15.03.2016 | Clinical Study

Seizures in patients with primary brain tumors: what is their psychosocial impact?

verfasst von: John Y. Shin, Sani H. Kizilbash, Steven I. Robinson, Joon H. Uhm, Julie E. Hammack, Daniel H. Lachance, Jan C. Buckner, Aminah Jatoi

Erschienen in: Journal of Neuro-Oncology | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Seizures occur in most patients with primary malignant tumors and are associated with poor quality of life. To our knowledge, no previous studies have sought descriptions of quality of life in patients’ own words. Patients with a history of a malignant primary brain tumor and seizures participated in semi-structured interviews, which were analyzed with qualitative methodology. Twenty-seven patients participated, most with high grade brain tumors. Most were receiving anti-seizure medication. Three distinct themes emerged: (1) the first seizure as a sentinel event, as manifested in part by how patients described their first seizure in remarkable detail (“I clearly remember the date…”); (2) seizures as inextricably tied to the brain tumor itself; for example, one patient explained how he “always wondered what was happening with my brain tumor” with each seizure; and (3) adaptation and acceptance—or lack therefore—to seizures. With respect to this third theme, patients conveyed frustration from an inability to work, to drive, and to take care of their children (“It’s like you are 15 all over again.”) Others described frustration with taking antiseizure medications (“I felt like an 80 year old, now taking her pills every day”). However, some patients had adapted or resigned themselves (“…so much of life is out of control—you just gotta take what you get.”). These findings have future research implications but should also serve to make healthcare providers more aware of the heavy emotional burden that seizures thrust upon brain tumor patients.
Literatur
1.
Zurück zum Zitat Shah U, Morrison T (2013) A review of the symptomatic management of malignant gliomas in adults. J Natl Compr Cancer Netw 11:424–429 Shah U, Morrison T (2013) A review of the symptomatic management of malignant gliomas in adults. J Natl Compr Cancer Netw 11:424–429
2.
Zurück zum Zitat Michelucci R, Pasini E, Meletti S et al (2013) Epilepsy in primary cerebral tumors: the characteristics of epilepsy at the onset (results from the PERNO study—project of Emilia Romagna region on neuro-oncology). Epilepsia 54(Supple 7):86–91CrossRefPubMed Michelucci R, Pasini E, Meletti S et al (2013) Epilepsy in primary cerebral tumors: the characteristics of epilepsy at the onset (results from the PERNO study—project of Emilia Romagna region on neuro-oncology). Epilepsia 54(Supple 7):86–91CrossRefPubMed
3.
Zurück zum Zitat Wick W, Menn O, Meisner C et al (2005) Pharmacotherapy of epileptic seizures in glioma patients: who, when, why and how long? Onkologie 28:391–396PubMed Wick W, Menn O, Meisner C et al (2005) Pharmacotherapy of epileptic seizures in glioma patients: who, when, why and how long? Onkologie 28:391–396PubMed
4.
Zurück zum Zitat Van Breemen MS, Rijsman RM, Taphoorn MJ et al (2009) Efficacy of anti-epileptic drugs in patients with gliomas and seizures. J Neurol 256:1519–1526CrossRefPubMed Van Breemen MS, Rijsman RM, Taphoorn MJ et al (2009) Efficacy of anti-epileptic drugs in patients with gliomas and seizures. J Neurol 256:1519–1526CrossRefPubMed
5.
Zurück zum Zitat Ruge MI, Ilmberger J, Tonn JC, Kreth FW (2011) Health-related quality of life and cognitive functioning in adult patients with supratentorial WHO grade II glioma: status prior to therapy. J Neurooncol 103:129–136CrossRefPubMed Ruge MI, Ilmberger J, Tonn JC, Kreth FW (2011) Health-related quality of life and cognitive functioning in adult patients with supratentorial WHO grade II glioma: status prior to therapy. J Neurooncol 103:129–136CrossRefPubMed
6.
Zurück zum Zitat Rahman Z, Wong CH, Dexter M et al (2015) Epilepsy in patients with primary brain tumors: the impact on mood, cognition, and HRQOL. Epilepsy Behav 48:88–95CrossRefPubMed Rahman Z, Wong CH, Dexter M et al (2015) Epilepsy in patients with primary brain tumors: the impact on mood, cognition, and HRQOL. Epilepsy Behav 48:88–95CrossRefPubMed
7.
Zurück zum Zitat Sato I, Higuchi A, Yanagisawa T et al (2014) Impact of late effects on health-related quality of life in survivors of pediatric brain tumors: motility disturbance of limbs, seizure, ocular/visual impairment, endocrine abnormality, and higher brain dysfunction. Cancer Nurs 37:E1–E14CrossRefPubMed Sato I, Higuchi A, Yanagisawa T et al (2014) Impact of late effects on health-related quality of life in survivors of pediatric brain tumors: motility disturbance of limbs, seizure, ocular/visual impairment, endocrine abnormality, and higher brain dysfunction. Cancer Nurs 37:E1–E14CrossRefPubMed
8.
Zurück zum Zitat Greenhalgh T, Annandale E, Ashccroft R et al (2016) An open letter to the BMJ editors on qualitative research. BMJ 352:i563CrossRefPubMed Greenhalgh T, Annandale E, Ashccroft R et al (2016) An open letter to the BMJ editors on qualitative research. BMJ 352:i563CrossRefPubMed
9.
10.
Zurück zum Zitat Curry LA, Spatz E, Cherlin E et al (2011) What distinguishes top-performing hospitals in acute myocardial infarction mortality rates? Ann Intern Med 154:384–390CrossRefPubMedPubMedCentral Curry LA, Spatz E, Cherlin E et al (2011) What distinguishes top-performing hospitals in acute myocardial infarction mortality rates? Ann Intern Med 154:384–390CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Brooks GA, Abrams TA, Meyerhardt JA et al (2014) Identification of potentially avoidable hospitalizations in patients with GI cancer. J Clin Oncol 32:496–503CrossRefPubMedPubMedCentral Brooks GA, Abrams TA, Meyerhardt JA et al (2014) Identification of potentially avoidable hospitalizations in patients with GI cancer. J Clin Oncol 32:496–503CrossRefPubMedPubMedCentral
12.
15.
Zurück zum Zitat Meyer J (2000) Qualitative research in health care. Using qualitative methods in health related action research. BMJ 320:50–52CrossRef Meyer J (2000) Qualitative research in health care. Using qualitative methods in health related action research. BMJ 320:50–52CrossRef
16.
Zurück zum Zitat Green J, Britten N (1997) Qualitative research and evidence based medicine. BMJ 315:740–743CrossRef Green J, Britten N (1997) Qualitative research and evidence based medicine. BMJ 315:740–743CrossRef
18.
Zurück zum Zitat May N, Pope C (1995) Rigour and qualitative research. BMJ 311:109–112CrossRef May N, Pope C (1995) Rigour and qualitative research. BMJ 311:109–112CrossRef
20.
Zurück zum Zitat Hewitt ME, Bamundo A, Day R, Harvey C (2007) Perspectives on post-treatment cancer care: qualitative research with survivors. J Clin Oncol 25:1691–1697CrossRef Hewitt ME, Bamundo A, Day R, Harvey C (2007) Perspectives on post-treatment cancer care: qualitative research with survivors. J Clin Oncol 25:1691–1697CrossRef
21.
Zurück zum Zitat Wager E, Williams P (2013) “Hardly worth the effort”? Medical journals’ policies and their editors’ and publishers’ views on trial registration and publication bias: quantitative and qualitative study. BMJ 347:5248CrossRef Wager E, Williams P (2013) “Hardly worth the effort”? Medical journals’ policies and their editors’ and publishers’ views on trial registration and publication bias: quantitative and qualitative study. BMJ 347:5248CrossRef
22.
Zurück zum Zitat Honda M, Wakita T, Onishi Y et al (2015) Development and validation of a disease-specific instrument to measure diet-targeted quality of life for postoperative patients with esophagogastric cancer. Ann Surg Oncol 22:848–854CrossRef Honda M, Wakita T, Onishi Y et al (2015) Development and validation of a disease-specific instrument to measure diet-targeted quality of life for postoperative patients with esophagogastric cancer. Ann Surg Oncol 22:848–854CrossRef
23.
Zurück zum Zitat Osbourne TR, Ramsenthaler C, Schey SA et al (2015) Improving the assessment of quality of life in the clinical care of myeloma patients: the development and validation of the myeloma outcome scale (MyPOS). BMC Cancer 15:280CrossRef Osbourne TR, Ramsenthaler C, Schey SA et al (2015) Improving the assessment of quality of life in the clinical care of myeloma patients: the development and validation of the myeloma outcome scale (MyPOS). BMC Cancer 15:280CrossRef
24.
Zurück zum Zitat Sepucha KR, Feibelmann S, Cosenza C et al (2014) Development and evaluation of a new survey instrument to measure the quality of colorectal cancer screening decisions. BMC Med Inform Decis Mak 14:72CrossRefPubMedPubMedCentral Sepucha KR, Feibelmann S, Cosenza C et al (2014) Development and evaluation of a new survey instrument to measure the quality of colorectal cancer screening decisions. BMC Med Inform Decis Mak 14:72CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat De Souza JA, Yap BJ, Hlubocky FJ et al (2014) The development of a financial toxicity patient-reported outcome in cancer: the COST measure. Cancer 120:3245–3253CrossRefPubMed De Souza JA, Yap BJ, Hlubocky FJ et al (2014) The development of a financial toxicity patient-reported outcome in cancer: the COST measure. Cancer 120:3245–3253CrossRefPubMed
26.
Zurück zum Zitat King MT, Stockler MR, Butow P et al (2014) Development of the measure of ovarian symptoms and treatment concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic ovarian cancer. Int J Gynecol Cancer 24:865–873CrossRefPubMed King MT, Stockler MR, Butow P et al (2014) Development of the measure of ovarian symptoms and treatment concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic ovarian cancer. Int J Gynecol Cancer 24:865–873CrossRefPubMed
27.
Zurück zum Zitat Winters ZE, Balta V, Thomson HK et al (2014) Phase III development of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire module for women undergoing breast reconstruction. Br J Surg 101:371–382CrossRefPubMed Winters ZE, Balta V, Thomson HK et al (2014) Phase III development of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire module for women undergoing breast reconstruction. Br J Surg 101:371–382CrossRefPubMed
28.
Zurück zum Zitat Williams LA, Agarwal S, Bodurka DC et al (2013) Capturing the patient’s experience: using qualitative research methods to develop a measure of patient-reported symptom burden: an example from ovarian cancer. J Pain Symptom Manag 46:837–845CrossRef Williams LA, Agarwal S, Bodurka DC et al (2013) Capturing the patient’s experience: using qualitative research methods to develop a measure of patient-reported symptom burden: an example from ovarian cancer. J Pain Symptom Manag 46:837–845CrossRef
29.
Zurück zum Zitat Flynn KE, Lin L, Cyranowski JM et al (2013) Development of the NIH PROMIS sexual function and satisfaction measures in patients with cancer. J Sex Med 10(Suppl 1):43–52CrossRefPubMedPubMedCentral Flynn KE, Lin L, Cyranowski JM et al (2013) Development of the NIH PROMIS sexual function and satisfaction measures in patients with cancer. J Sex Med 10(Suppl 1):43–52CrossRefPubMedPubMedCentral
Metadaten
Titel
Seizures in patients with primary brain tumors: what is their psychosocial impact?
verfasst von
John Y. Shin
Sani H. Kizilbash
Steven I. Robinson
Joon H. Uhm
Julie E. Hammack
Daniel H. Lachance
Jan C. Buckner
Aminah Jatoi
Publikationsdatum
15.03.2016
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 2/2016
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-016-2108-y

Weitere Artikel der Ausgabe 2/2016

Journal of Neuro-Oncology 2/2016 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.